Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) Seeking Recovery for Investors – Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...
Guggenheim lowers Regeneron price target, says selloff ‘overdone’
Guggenheim lowered the firm’s price target on Regeneron (REGN) to $950 from $1,200 and keeps a Buy rating on the shares. The firm, which is ...
Regeneron Gets New FDA Review of Linvoseltamab for Multiple Myeloma
Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
This was the stock's second consecutive day of losses.
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...
Kalkine Media5d
Is Regeneron Pharmaceuticals (NASDAQ:REGN) Strengthening Its Position in the Biopharmaceutical Industry
Highlights,Financial firms have revised their evaluations of Regeneron Pharmaceuticals.,The company reported strong earnings, ...
Kalkine Media6d
Can Regeneron Pharmaceuticals Shape the Future of Biopharma?
Highlights,Revised valuation estimates from reputable financial sources (NASDAQ:REGN),Strong quarterly earnings with revenue ...